|
Drug Uses
Gris-PEG is prescribed for the treatment of the following
ringworm infections: Athlete's foot, Barber's itch (inflammation
of the facial hair follicles), Ringworm of the body, Ringworm
of the groin and thigh, Ringworm of the nails, Ringworm of
the scalp. Because Gris-PEG is effective only for certain
types of fungal infections, before treatment your doctor may
perform tests to identify the source of infection.
Accurate diagnosis of the infecting organism is essential.
Adults: Daily administration of 330 mg (as a single dose or
in divided amounts) will give a satisfactory response. Children:
Approximately 3.3 mg per pound of body weight per day is an
effective dose for most children.
Because Gris-PEG can make you sensitive to light, avoid exposure
to intense natural or artificial sunlight. Notify your doctor
if you develop lupus erythematosus (a form of rheumatism)
or a lupus-like condition. Signs and symptoms of lupus include
arthritis, red butterfly rash over the nose and cheeks, tiredness,
weakness, sensitivity to sunlight, and skin eruptions. If
you are being treated with Gris-PEG for an extended period
of time, your doctor should perform regular tests, including
periodic monitoring of kidney function, liver function, and
blood cell production. Gris-PEG has not been proved safe and
effective for the prevention of fungal infections. Gris-PEG
may decrease the effectiveness of birth-control pills. Use
additional protection while you are taking Gris-PEG. Men should
wait at least 6 months after finishing therapy with Gris-PEG
before they father a child. Women should avoid becoming pregnant
while they are taking the drug.
Take the missed dose as soon as you remember. If it is almost
time for your next dose, skip the one you missed and go back
to your regular schedule. Do not take 2 doses at once.
When adverse reactions occur, they are most commonly of the
hypersensitivity type such as skin rashes, urticaria, erythema
multiform-like drug reactions, and rarely, angioneurotic edema,
and may necessitate withdrawal of therapy and appropriate
countermeasures. Paresthesias of the hands and feet have been
reported rarely after extended therapy. Other side effects
reported occasionally are oral thrush, nausea, vomiting, epigastria
distress, diarrhea, headache, fatigue, dizziness, insomnia,
mental confusion, and impairment of performance of routine
activities. Administration of the drug should be discontinued
if granulocytopenia occur. When rare, serious reactions occur
with Gris-PEG, they are usually associated with high dosages,
long periods of therapy, or both.
Store Gris-PEG tablets at controlled room temperature 15?-30?C
(59?-86?F) in tight, light-resistant containers.
Any medication taken in excess can have dangerous consequences.
If you suspect an overdose of Gris-PEG, seek emergency medical
treatment immediately.
Gris-PEG may intensify the effects of alcohol. If you drink
alcohol while taking this medication, your heart may start
beating faster and your skin may be flushed. If Gris-PEG is
taken with certain other drugs, the effects could be increased,
decreased, or altered. It is especially important to check
with your doctor before combining Gris-PEG with the following:
Blood-thinning drugs such as Coumadin, Barbiturates such as
Phenobarbital, Oral Contraceptives.
| Description |
Price |
Order Now |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This drug information is for
your information purposes only, it is not intended that this
information covers all uses, directions, drug interactions,
precautions, or adverse effects of your medication. This is
only general information, and should not be relied on for
any purpose, it should not be construed as containing specific
instructions for any particular patient. epsdrugstore.com
disclaims all responsibility for the accuracy of, and reliability
of this information, and or any consequences arising from
the use of this information, including damage or adverse consequences
to persons or property, however such damages or consequences
arise. No warranty, either expressed or implied, is made in
regards to the contents of this material. |
